IPP Bureau
Moderna to set up mRNA manufacturing in Canada
By IPP Bureau - August 11, 2021
The collaboration will support Canada with direct access to rapid pandemic response capabilities
Pear Therapeutics’ three FDA authorised prescriptions available at OptumRx
By IPP Bureau - August 11, 2021
OptumRx to make Pear’s three commercial Prescription Digital Therapeutics accessible to patients with Optum formulary access.
Tesis Labs and Personal Genome Diagnostics tie-up to advance cancer treatment
By IPP Bureau - August 11, 2021
The aim is to create new genomics solutions that could combat cancer and advance market access
Global Healthcare Supply Chain Management market to reach US $ 3.6 billion by 2026
By IPP Bureau - August 11, 2021
A new market study published by Global Industry Analysts (GIA), released its report titled, ``Healthcare Supply Chain Management—Global Market Trajectory & Analytics.’’ We present excerpts from the report
Penpulimab Monoclonal Antibody (PD-1) Obtains Marketing Approval in China
By IPP Bureau - August 11, 2021
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
GSK files application for MMR vaccine in the US
By IPP Bureau - August 11, 2021
If approved it will bring a second source of MMR vaccine to the US market
GW Pharmaceuticals receives approval for Epidyolex to treat seizures
By IPP Bureau - August 11, 2021
TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
Cadila Healthcare net profit at Rs 587.2 cr in Q1FY22
By IPP Bureau - August 11, 2021
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
Marksons Pharma PAT at Rs 62.6 cr. for Q1FY22
By IPP Bureau - August 11, 2021
The company has tied up with OrbiMed as a financial partner for global reach
Lupin posts net profit of Rs 542.46 cr. in Q1FY22
By IPP Bureau - August 11, 2021
The profits were bolstered by the Boehringer Ingelheim MEK program income
Sequent Scientific net profit at Rs 87.30 lakh in Q1FY22
By IPP Bureau - August 11, 2021
Formulation business grew by 15 per cent in the quarter
Krishna Institute of Medical Sciences PAT at Rs 89.12 cr for Q1FY22
By IPP Bureau - August 11, 2021
KIMS Hospitals' brand, has an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021
NPPA has put a cap on the trade margin of 42 select non-scheduled anti-cancer medicines
By IPP Bureau - August 11, 2021
A total of 526 brands has seen a reduction of up to 90 per cent in MRP
SMS Pharmaceuticals revenue grows by 44%; Profit up 235%
By IPP Bureau - August 10, 2021
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
Bayer strengthens drug discovery platform through acquisition of Vividion Therapeutics
By IPP Bureau - August 10, 2021
Purchase price of US $ 1.5 billion upfront and up to USD 500 million in success-based milestone payments
